Biofrontera Inc.
BFRI
$1.54
-$0.02-1.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 61.64% | 3.82% | 40.67% | -36.89% | -22.81% |
| Total Depreciation and Amortization | -16.84% | -21.21% | -24.46% | -28.95% | -16.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.04% | 116.72% | -263.28% | 108.41% | 115.62% |
| Change in Net Operating Assets | -163.40% | -94.13% | -156.08% | 376.87% | 1,352.02% |
| Cash from Operations | 15.55% | 15.80% | -30.10% | 33.76% | 50.37% |
| Capital Expenditure | 40.00% | -109.09% | 80.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -100.00% |
| Cash from Investing | 60,040.00% | 50,033.33% | 100,033.33% | -105.63% | -101.10% |
| Total Debt Issued | -- | -- | -- | -65.39% | -79.28% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 98.57% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 41.61% | 41.61% | 10.94% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | -- | -- | -- | -- |
| Cash from Financing | -80.82% | 20.08% | -26.86% | -28.28% | -33.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -190.21% | 323.03% | -89.32% | 199.09% | 3,964.86% |